首页> 美国卫生研究院文献>Cancer Biotherapy Radiopharmaceuticals >Cancer Stem Cell Targeting Using the Alpha-Particle Emitter 213Bi: Mathematical Modeling and Feasibility Analysis
【2h】

Cancer Stem Cell Targeting Using the Alpha-Particle Emitter 213Bi: Mathematical Modeling and Feasibility Analysis

机译:癌症干细胞靶向使用α-颗粒发射体213Bi:数学建模和可行性分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is increasing recognition that treatment failure in cancer may be associated with the failure to sterilize a small subpopulation of tumor cells that have been characterized as tumor stem cells. Defined as cells that are able to self-renew and also to replenish a phenotypically diverse tumor-cell population, such cells are also considered resistant to chemotherapy. These characteristics are optimal for targeting by using alpha-particle-emitting radionuclides. Because of their high-energy deposition density per track, alpha-particles are capable of targeting single cells or small clusters of cells with minimal normal organ toxicity. The DNA damage induced by alpha-particles is largely irreparable and, therefore, alpha-particle-induced damage is minimally susceptible to resistance mechanisms. In this work, theoretical modeling was performed to examine the potential of alpha-emitter targeting of such small clusters of cancer stem cells. Critical parameters influencing efficacy and toxicity were identified and their relationship elucidated. The results identify specific activity, antigen site density, and number of target cells as critical parameters for effective cell killing and demonstrate substantial efficacy gains by targeting a smaller number of stem cells, as opposed to the entire tumor-cell population.
机译:人们越来越认识到,癌症的治疗失败可能与未能对已被表征为肿瘤干细胞的肿瘤细胞小亚群进行灭菌有关。被定义为能够自我更新并补充表型多样的肿瘤细胞群体的细胞,这种细胞也被认为对化学疗法具有抗性。这些特性是使用发射α粒子的放射性核素进行靶向的最佳选择。由于它们的每条轨道具有高能量沉积密度,因此α粒子能够以最小的正常器官毒性靶向单细胞或小细胞簇。由α粒子引起的DNA损伤在很大程度上是无法弥补的,因此,由α粒子引起的损伤对耐药机制的影响极小。在这项工作中,进行了理论建模,以检查这种小型癌症干细胞簇靶向α-发射体的潜力。确定了影响功效和毒性的关键参数,并阐明了它们之间的关系。结果确定了比活性,抗原位点密度和靶细胞数量作为有效杀伤细胞的关键参数,并通过靶向较少数量的干细胞而不是整个肿瘤细胞群体证明了实质性的疗效提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号